REIT - Healthcare Facilities
Compare Stocks
5 / 10Stock Comparison
GMRE vs CHCT vs NXRT vs NTST vs HR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Residential
REIT - Retail
REIT - Healthcare Facilities
GMRE vs CHCT vs NXRT vs NTST vs HR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Residential | REIT - Retail | REIT - Healthcare Facilities |
| Market Cap | $94M | $505M | $756M | $1.70B | $6.98B |
| Revenue (TTM) | $148M | $122M | $252M | $176M | $1.15B |
| Net Income (TTM) | $2M | $6M | $-32M | $185K | $-201M |
| Gross Margin | 68.8% | 62.8% | 91.1% | 92.4% | -9.7% |
| Operating Margin | 24.9% | 31.3% | 11.5% | 27.7% | 19.5% |
| Forward P/E | 595.7x | 37.6x | — | 64.8x | — |
| Total Debt | $654M | $536M | $1.56B | $0.00 | $4.15B |
| Cash & Equiv. | $7M | $3M | $14M | $14M | $26M |
GMRE vs CHCT vs NXRT vs NTST vs HR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | Mar 26 | Return |
|---|---|---|---|
| Global Medical REIT… (GMRE) | 100 | 55.9 | -44.1% |
| Community Healthcar… (CHCT) | 100 | 36.6 | -63.4% |
| NexPoint Residentia… (NXRT) | 100 | 68.1 | -31.9% |
| NETSTREIT Corp. (NTST) | 100 | 113.2 | +13.2% |
| Healthcare Realty T… (HR) | 100 | 64.0 | -36.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GMRE vs CHCT vs NXRT vs NTST vs HR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GMRE ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs NXRT's 211.1%
- 63.5% yield, 5-year raise streak, vs NXRT's 7.1%
CHCT carries the broadest edge in this set and is the clearest fit for value and quality.
- Better valuation composite
- 5.0% margin vs HR's -17.5%
- 0.6% ROA vs HR's -2.1%, ROIC 1.6% vs 0.7%
Among these 5 stocks, NXRT doesn't own a clear edge in any measured category.
NTST is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 30.0%, EPS growth 150.0%, 3Y rev CAGR 28.2%
- 30.0% FFO/revenue growth vs HR's -6.9%
- Beta 0.05 vs NXRT's 0.62
HR is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.13, Low D/E 88.7%, current ratio 1.75x
- Beta 0.13, yield 5.5%, current ratio 1.75x
- +38.2% vs NXRT's -15.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.0% FFO/revenue growth vs HR's -6.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 5.0% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.05 vs NXRT's 0.62 | |
| Dividends | 63.5% yield, 5-year raise streak, vs NXRT's 7.1% | |
| Momentum (1Y) | +38.2% vs NXRT's -15.2% | |
| Efficiency (ROA) | 0.6% ROA vs HR's -2.1%, ROIC 1.6% vs 0.7% |
GMRE vs CHCT vs NXRT vs NTST vs HR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
GMRE vs CHCT vs NXRT vs NTST vs HR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GMRE leads in 1 of 6 categories
NTST leads 1 • CHCT leads 0 • NXRT leads 0 • HR leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CHCT and NTST each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HR is the larger business by revenue, generating $1.1B annually — 9.4x CHCT's $122M. CHCT is the more profitable business, keeping 5.0% of every revenue dollar as net income compared to HR's -17.5%. On growth, NTST holds the edge at +27.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $148M | $122M | $252M | $176M | $1.1B |
| EBITDAEarnings before interest/tax | $95M | $82M | $125M | $133M | $767M |
| Net IncomeAfter-tax profit | $2M | $6M | -$32M | $185,000 | -$201M |
| Free Cash FlowCash after capex | $19M | $60M | $79M | $106M | $201M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +62.8% | +91.1% | +92.4% | -9.7% |
| Operating MarginEBIT ÷ Revenue | +24.9% | +31.3% | +11.5% | +27.7% | +19.5% |
| Net MarginNet income ÷ Revenue | +1.7% | +5.0% | -12.7% | +0.1% | -17.5% |
| FCF MarginFCF ÷ Revenue | +12.6% | +49.4% | +31.2% | +59.9% | +17.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.7% | +4.8% | +0.5% | +27.7% | -10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -166.2% | +124.4% | 0.0% | +110.6% | +99.8% |
Valuation Metrics
GMRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 115.3x trailing earnings, GMRE trades at a 55% valuation discount to NTST's 254.5x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than NXRT's 18.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $94M | $505M | $756M | $1.7B | $7.0B |
| Enterprise ValueMkt cap + debt − cash | $741M | $1.0B | $2.3B | $1.7B | $11.1B |
| Trailing P/EPrice ÷ TTM EPS | 115.29x | 228.42x | -23.65x | 254.50x | -28.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 595.67x | 37.62x | — | 64.78x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 4.35x | — |
| EV / EBITDAEnterprise value multiple | 8.35x | 16.27x | 18.60x | 12.34x | 16.84x |
| Price / SalesMarket cap ÷ Revenue | 0.68x | 4.17x | 3.01x | 8.72x | 5.91x |
| Price / BookPrice ÷ Book value/share | 0.17x | 1.11x | 2.52x | 1.18x | 1.50x |
| Price / FCFMarket cap ÷ FCF | — | 8.95x | 9.05x | 15.52x | 54.95x |
Profitability & Efficiency
Evenly matched — CHCT and NTST each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CHCT delivers a 1.4% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-10 for NXRT. HR carries lower financial leverage with a 0.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), HR scores 7/9 vs NXRT's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.5% | +1.4% | -10.1% | +0.0% | -4.3% |
| ROA (TTM)Return on assets | +0.2% | +0.6% | -1.7% | +0.0% | -2.1% |
| ROICReturn on invested capital | +2.0% | +1.6% | +1.1% | +2.1% | +0.7% |
| ROCEReturn on capital employed | +5.3% | +2.8% | +1.5% | +2.1% | +1.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 4 | 6 | 7 |
| Debt / EquityFinancial leverage | 1.18x | 1.25x | 5.18x | — | 0.89x |
| Net DebtTotal debt minus cash | $647M | $533M | $1.5B | -$14M | $4.1B |
| Cash & Equiv.Liquid assets | $7M | $3M | $14M | $14M | $26M |
| Total DebtShort + long-term debt | $654M | $536M | $1.6B | $0 | $4.1B |
| Interest CoverageEBIT ÷ Interest expense | 1.14x | 1.15x | 0.47x | — | -0.21x |
Total Returns (Dividends Reinvested)
NTST leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTST five years ago would be worth $11,488 today (with dividends reinvested), compared to $5,441 for CHCT. Over the past 12 months, HR leads with a +38.2% total return vs NXRT's -15.2%. The 3-year compound annual growth rate (CAGR) favors NTST at 8.3% vs CHCT's -13.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +6.9% | +11.2% | +2.6% | +15.8% | +19.4% |
| 1-Year ReturnPast 12 months | +0.1% | +14.5% | -15.2% | +32.6% | +38.2% |
| 3-Year ReturnCumulative with dividends | +5.6% | -36.1% | -15.5% | +27.0% | +17.5% |
| 5-Year ReturnCumulative with dividends | -21.4% | -45.6% | -23.0% | +14.9% | +1.1% |
| 10-Year ReturnCumulative with dividends | +308.1% | +83.9% | +211.1% | +40.7% | +39.6% |
| CAGR (3Y)Annualised 3-year return | +1.8% | -13.9% | -5.5% | +8.3% | +5.5% |
Risk & Volatility
Evenly matched — NTST and HR each lead in 1 of 2 comparable metrics.
Risk & Volatility
NTST is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than NXRT's 0.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HR currently trades 97.7% from its 52-week high vs NXRT's 77.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.60x | 0.62x | 0.05x | 0.13x |
| 52-Week HighHighest price in past year | $39.93 | $18.22 | $38.30 | $21.30 | $20.46 |
| 52-Week LowLowest price in past year | $29.05 | $13.23 | $23.79 | $15.24 | $14.09 |
| % of 52W HighCurrent price vs 52-week peak | +89.5% | +97.0% | +77.8% | +95.6% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 52.7 | 56.9 | 71.0 | 57.7 | 77.5 |
| Avg Volume (50D)Average daily shares traded | 130K | 228K | 216K | 1.2M | 3.5M |
Analyst Outlook
Evenly matched — GMRE and NXRT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GMRE as "Buy", CHCT as "Hold", NXRT as "Hold", NTST as "Buy", HR as "Hold". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -9.4% for NXRT (target: $27). For income investors, GMRE offers the higher dividend yield at 63.51% vs NTST's 4.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $40.00 | $18.50 | $27.00 | $22.03 | $19.33 |
| # AnalystsCovering analysts | 22 | 16 | 10 | 18 | 29 |
| Dividend YieldAnnual dividend ÷ price | +63.5% | +11.3% | +7.1% | +4.1% | +5.5% |
| Dividend StreakConsecutive years of raises | 5 | 11 | 12 | 0 | 0 |
| Dividend / ShareAnnual DPS | $22.70 | $2.00 | $2.11 | $0.83 | $1.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.4% | +1.0% | +0.0% | +0.1% |
GMRE leads in 1 of 6 categories (Valuation Metrics). NTST leads in 1 (Total Returns). 4 tied.
GMRE vs CHCT vs NXRT vs NTST vs HR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GMRE or CHCT or NXRT or NTST or HR a better buy right now?
For growth investors, NETSTREIT Corp.
(NTST) is the stronger pick with 30. 0% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GMRE or CHCT or NXRT or NTST or HR?
On trailing P/E, Global Medical REIT Inc.
(GMRE) is the cheapest at 115. 3x versus NETSTREIT Corp. at 254. 5x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GMRE or CHCT or NXRT or NTST or HR?
Over the past 5 years, NETSTREIT Corp.
(NTST) delivered a total return of +14. 9%, compared to -45. 6% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus HR's +39. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GMRE or CHCT or NXRT or NTST or HR?
By beta (market sensitivity over 5 years), NETSTREIT Corp.
(NTST) is the lower-risk stock at 0. 05β versus NexPoint Residential Trust, Inc. 's 0. 62β — meaning NXRT is approximately 1156% more volatile than NTST relative to the S&P 500. On balance sheet safety, Healthcare Realty Trust Incorporated (HR) carries a lower debt/equity ratio of 89% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GMRE or CHCT or NXRT or NTST or HR?
By revenue growth (latest reported year), NETSTREIT Corp.
(NTST) is pulling ahead at 30. 0% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: NETSTREIT Corp. grew EPS 150. 0% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, NTST leads at 28. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GMRE or CHCT or NXRT or NTST or HR?
Global Medical REIT Inc.
(GMRE) is the more profitable company, earning 4. 8% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTST leads at 25. 7% versus 8. 0% for HR. At the gross margin level — before operating expenses — NTST leads at 99. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GMRE or CHCT or NXRT or NTST or HR more undervalued right now?
On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.
6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — GMRE or CHCT or NXRT or NTST or HR?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 4. 1% for NETSTREIT Corp. (NTST).
09Is GMRE or CHCT or NXRT or NTST or HR better for a retirement portfolio?
For long-horizon retirement investors, NETSTREIT Corp.
(NTST) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05), 4. 1% yield). Both have compounded well over 10 years (NTST: +40. 7%, CHCT: +83. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GMRE and CHCT and NXRT and NTST and HR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GMRE is a small-cap income-oriented stock; CHCT is a small-cap income-oriented stock; NXRT is a small-cap income-oriented stock; NTST is a small-cap high-growth stock; HR is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.